Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot manufacturing facility in Holly Springs. The company expects to employ 420 ...

Regeneron Pharmaceuticals said on Tuesday it has signed a deal worth more than $3 billion with contract drug developer ...

Regeneron (REGN) announced an expansion of ... In addition, the company is constructing a brand new fill/finish manufacturing facility in Rensselaer, New York, and has acquired an over 1 million ...

Regeneron said it will be building a new fill/finish manufacturing facility in Rensselaer, New York. Additionally, the company has acquired a property of over 1 million square feet in Saratoga ...

Regeneron, already one of the largest manufacturers ... In addition, the company is constructing a brand new, state-of-the-art fill/finish manufacturing facility in Rensselaer, New York, and ...

The ten-year partnership, valued at over $3 billion, is expected to complement Regeneron’s ongoing infrastructure growth, including a $3.6 billion expansion at its Tarrytown, NY, campus; a new ...

The latest analyst rating for Regeneron Pharmaceuticals (NASDAQ:REGN) was provided by Guggenheim, and Regeneron Pharmaceuticals maintained their buy rating. The last upgrade for Regeneron ...

Regeneron is also expanding its Tarrytown, New York-based facility and building a separate facility in the state to expand capacity to fill injection pens - a process known as fill-finish.